chr5-10981586-A-AACAC
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_001332.4(CTNND2):c.3417+183_3417+186dupGTGT variant causes a intron change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0064 ( 8 hom., cov: 20)
Consequence
CTNND2
NM_001332.4 intron
NM_001332.4 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -1.53
Genes affected
CTNND2 (HGNC:2516): (catenin delta 2) This gene encodes an adhesive junction associated protein of the armadillo/beta-catenin superfamily and is implicated in brain and eye development and cancer formation. The protein encoded by this gene promotes the disruption of E-cadherin based adherens junction to favor cell spreading upon stimulation by hepatocyte growth factor. This gene is overexpressed in prostate adenocarcinomas and is associated with decreased expression of tumor suppressor E-cadherin in this tissue. This gene resides in a region of the short arm of chromosome 5 that is deleted in Cri du Chat syndrome. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 5-10981586-A-AACAC is Benign according to our data. Variant chr5-10981586-A-AACAC is described in ClinVar as [Likely_benign]. Clinvar id is 1318181.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00637 (958/150460) while in subpopulation AFR AF= 0.0202 (832/41102). AF 95% confidence interval is 0.0191. There are 8 homozygotes in gnomad4. There are 463 alleles in male gnomad4 subpopulation. Median coverage is 20. This position pass quality control queck.
BS2
High AC in GnomAd4 at 958 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNND2 | NM_001332.4 | c.3417+183_3417+186dupGTGT | intron_variant | ENST00000304623.13 | NP_001323.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTNND2 | ENST00000304623.13 | c.3417+183_3417+186dupGTGT | intron_variant | 1 | NM_001332.4 | ENSP00000307134.8 |
Frequencies
GnomAD3 genomes AF: 0.00639 AC: 961AN: 150352Hom.: 8 Cov.: 20
GnomAD3 genomes
AF:
AC:
961
AN:
150352
Hom.:
Cov.:
20
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.00637 AC: 958AN: 150460Hom.: 8 Cov.: 20 AF XY: 0.00630 AC XY: 463AN XY: 73434
GnomAD4 genome
AF:
AC:
958
AN:
150460
Hom.:
Cov.:
20
AF XY:
AC XY:
463
AN XY:
73434
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 05, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at